Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: Impact on the international normalized ratio system

Haematologica

Volumn 87, Issue 12, 2002, Pages 1265-1273

  Testa, Sophie ^a   Morstabilini, Giampietro ^a   Fattorini, Annalisa ^b   Galli, Laura ^b   Denti, Nadia ^a   D'Angelo, Armando ^b  

^a Istituto di Patologia Clinica   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Factor V; INR; INR calibrator plasma; Oral anticoagulation; Prothrombin time; Vitamin K dependent clotting factors

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; PROTHROMBIN; REAGENT; RECOMBINANT THROMBOPLASTIN; THROMBOPLASTIN; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CALIBRATION; CALIBRATOR; CONTROLLED STUDY; FEMALE; HUMAN; INSTRUMENT; INTERNATIONAL STANDARD UNIT; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PLASMA; PROTHROMBIN TIME; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTICOAGULANTS; BIAS (EPIDEMIOLOGY); BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CALIBRATION; FEMALE; HUMANS; INDICATORS AND REAGENTS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROTHROMBIN TIME; SENSITIVITY AND SPECIFICITY; THROMBOPLASTIN;

EID: 0036902982     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Guidelines for Thromboplastins and Plasma Used to Control Oral Anticoagulant Therapy. WHO Expert Committee in Biological Standardisation. WHO Technical Report Series. 1999; 889:64-93.
2. Goguel AF, Roussi JH, Houbouyan LL. A new approach in one-stage prothrombin time standardisation: Use of calibrated control plasma. Proceedings Vth International Congress on Thromboembolism, Bologna, Italy, 1978.
3. Poiler L, Triplett DA, Hirsh J, Carroll J, Clarke K. The value of plasma calibrants in correcting coagulometer effects on international normalized ratios. An international multicenter study. Am J Clin Pathol 1995; 103:358-65.
4. Tripodi A, Chantarangkul V, Manotti C, Poggi M, Braga M, Akkawat B, et al. A simplified procedure for thromboplastin calibration: The usefulness of lyophilized plasmas assessed in a collaborative study. Thromb Haemost 1996; 75:309-12.
5. Houbouyan LL, Goguel AF. Long-term French experience in INR standardization by a procedure using plasma calibrants. Am J Clin Pathol 1997; 108:83-9.
6. Johnston M, Brigden M. A cross-Canada survey of prothrombin time testing: Does the establishment of local ISI values improve the accuracy of international normalized ratio reporting? Thrombosis Interest Group of Canada. Am J Clin Pathol 1998; 110:683-90.
7. Chantarangkul V, Tripodi A, Cesana BM, Mannucci PM. Calibration of local systems with lyophilized calibrant plasmas improves the interlaboratory variability of the INR in the Italian external quality assessment scheme. Thromb Haemost 1999; 82:1621-6.
8. D'Angelo A, Seveso MP, D'Angelo SV, Gilardoni F, Macagni A, Manotti C, et al. Comparison of two automated coagulometers and the manual tilt-tube method for the determination of prothrombin time. Am J Clin Pathol 1989; 92:321-8.
9. Poggio M, van den Besselaar AM, van der Velde EA, Bertina RM. The effect of some instruments for prothrombin time testing on the International Sensitivity Index (ISI) of two rabbit tissue thromboplastin reagents. Thromb Haemost 1989; 62:868-74.
10. Kitchen S, Walker ID, Woods TA, Preston FE. Thromboplastin related differences in the determination of international normalised ratio: A cause for concern? Steering Committee of the UK National External Quality Assessment Scheme in Blood Coagulation. Thromb Haemost 1994; 72:426-9.
11. Poller L, Thomson JM, Taberner DA, Clarke DK. The correction of coagulometer effects on international normalized ratios: A multicentre evaluation. Br J Haematol 1994; 86: 112-7.
12. Riley RS, Rowe D, Fisher LM. Clinical utilization of the international normalized ratio (INR). J Clin Lab Anal 2000; 14:101-14.
13. Lind SE, Callas PW Golden EA, Joyner KA, Ortel TL. Plasma levels of factors II, VII and X and their relationship to the international normalized ratio during chronic warfarin therapy. Blood Coagul Fibrinolysis 1997; 8:48-53.
14. Ma Xi, Béquin S, Hemker HC. The relative importance of factor II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thromb Haemost 1989; 62:788-91.
15. Lang H, Scheer B, Moritz B, Legenstein E, Kaiser E, Fischer M. International normalized ratio (INR)-proficiency tests by ®QUASTA for the prothrombin time: use of plasma from donors under oral anticoagulation. Hämostaseologie 1995; 15:41-8.
16. Vigano D'Angelo S, Gilardoni F, D'Angelo A. Evaluation of coagulometric assays in the assessment of protein C anticoagulant activity; variable sensitivity of commercial APTT reagents to the cofactor effect of protein S. Thromb Haemost 1989; 62:861-7.
17. Tomenson JA. A statistician's independent evaluation. In: van den Besselaar AM, Gralnick HR, Lewis SM, editors. Thromboplastin calibration and oral anticoagulant control. Martinus Nijhoff Publishers; Boston: 1984. p, 87-108.
18. Duncan EM, Casey CR, Duncan BM, Lloyd JV. Effect of concentration of trisodium citrate anticoagulant on calculation of the international normalised ratio and the international sensitivity index of thromboplastin. Thromb Haemost 1994; 72:84-8.
19. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-10.
20. Roussi J, Drouet L, Samama M, Sié P. French multicentric evaluation of recombinant tissue factor (Recombiplastin) for determination of prothrombin time. Thromb Haemost 1994; 72:698-704.
21. Watson C, Kitchen S, Woolley AM, Young L, Malia RG. Recombinant and tissue extract thromboplastins for determination of international normalised ratio in over-anticoagulated patients. Br J Biomed Sci 1999; 56:123-7
22. Van den Besselaar AM. International normalized ratio: Towards improved accuracy. Thromb Haemost 1999; 82: 1562-3.
23. D'Angelo A, Galli L, Lang H. Comparison of mean normal prothrombin time (PT) with PT of fresh normal pooled plasma or of a lyophilized control plasma (R82A) as denominator to express PT results: Collaborative study of the International Federation of Clinical Chemistry. IFCC Working Group Standardization of Coagulation Tests. Clin Chem 1997; 43:2169-74.
24. D'Angelo A, Della Valle P, Crippa L, Fattorini A, Pattarini E, Vigano D'Angelo S. Relationship between INR values, factor II clotting levels and in vivo prothrombin activation during the early and steady phase of oral anticoagulant treatment. Haematologica 2002; 87:1074-80.